ClinConnect ClinConnect Logo
Search / Trial NCT05520593

Preoperative Oral Hydration in the Ambulatory Arthroplasty Population

Launched by HOSPITAL FOR SPECIAL SURGERY, NEW YORK · Aug 25, 2022

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

Carbohydrate Drink Perioperative Fluids Same Day Discharge Total Joint Arthroplasty Nausea Vomiting Same Day Total Hip Arthroplasty Same Day Total Knee Arthroplasty

ClinConnect Summary

This clinical trial is exploring whether drinking a special carbohydrate drink before surgery can help patients have shorter hospital stays after undergoing joint replacement surgeries, like total knee or hip arthroplasty. The goal is to see if this drink can help patients recover quickly enough to go home on the same day of their surgery, which is referred to as same-day discharge.

To participate, individuals need to be scheduled for one of these surgeries and agree to go home the same day. They should also have someone responsible who can be with them overnight after the surgery. However, not everyone can join; for example, those with certain medical conditions like diabetes or chronic kidney disease, or those who are pregnant, will not be eligible. If you decide to take part in this study, you will be asked to drink the carbohydrate drink before your surgery and then monitored to see how it affects your recovery. This trial is currently looking for participants, so it's a chance to contribute to important research that could improve recovery experiences for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Candidates for ambulatory total knee arthroplasty
  • Candidates for ambulatory total hip arthroplasty
  • Candidates for ambulatory revision knee arthroplasty (liner exchange only)
  • Candidates for ambulatory revision hip arthroplasty (liner exchange only)
  • Case scheduled before noon (12 pm)
  • Patient agrees to same-day discharge and has a responsible adult to spend the night on the day of discharge
  • Exclusion Criteria:
  • BMI less than 18.5 or greater than 37.0
  • Patients with diabetes, chronic kidney disease, clotting disorders, or neurological conditions preventing control of the affected limb.
  • Pregnant women
  • Patients scheduled as ambulatory due to insurance mandates
  • Patients with a history of active ischemia, significant valvular disease, significant arrhythmias, obstructive sleep apnea as per Hospital for Special Surgery guidelines, chronic opioid dependence (chronic daily opioid use for six or more months), and glomerular filtration rate \< 60ml/min.

About Hospital For Special Surgery, New York

The Hospital for Special Surgery (HSS) in New York is a world-renowned institution specializing in orthopedic surgery, rheumatology, and rehabilitation. Recognized for its commitment to advancing medical research and improving patient outcomes, HSS serves as a leading clinical trial sponsor, facilitating innovative studies that explore cutting-edge treatments and therapies. With a team of expert clinicians and researchers, HSS aims to enhance clinical practices through rigorous scientific inquiry, ultimately contributing to the advancement of musculoskeletal health and patient care on a global scale.

Locations

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Jose A Rodriguez, MD

Principal Investigator

Hospital for Special Surgery, New York

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials